Literature DB >> 28482669

Evaluation of miR-22 and miR-20a as diagnostic biomarkers for gastric cancer.

Zahra Jafarzadeh-Samani1, Sareh Sohrabi1, Khadije Shirmohammadi1, Hosein Effatpanah1, Reza Yadegarazari1, Massoud Saidijam2.   

Abstract

BACKGROUND: Gastric cancer (GC) is the fourth most common cancers and the second reason for cancer-related death around the world, particularly in East Asian countries. Diagnosing GC in its early stages is followed by more successful treatment. Unfortunately, there is no accurate method for GC diagnosis in its early stages. Recently, miRNAs have been investigated in the most cancer researches which have demonstrated that they have been dysregulated in many cancers.
METHODS: This case-control study aims to investigate the expression rate of miR-22 and miR-20a in 32 cancerous tissues as well as 32 healthy adjacent tissues. Quantitative reverse transcriptase PCR (q-RT PCR) was used for investigating the expression rate of these miRNAs.
RESULTS: The expression rate of miR-20a in cancerous tissues was significantly increased (8.9 times) in comparison with their healthy tissues (P<0.001), while the expression rate of miR-22 in cancerous tissues was significantly decreased (1.9 times) (P<0.05).
CONCLUSIONS: The obtained results suggest miR-22 and miR-20a as good diagnostic biomarkers for early detection of GC. However more research is needed to investigate their efficacy.

Entities:  

Keywords:  Biomarkers; miR-20a; miR-22; stomach neoplasms

Mesh:

Substances:

Year:  2017        PMID: 28482669     DOI: 10.21037/cco.2017.03.01

Source DB:  PubMed          Journal:  Chin Clin Oncol        ISSN: 2304-3865


  9 in total

1.  MicroRNA-100 suppresses human gastric cancer cell proliferation by targeting CXCR7.

Authors:  Yongfeng Cao; Jiaye Song; Jianjuan Ge; Zhuchen Song; Jia Chen; Changping Wu
Journal:  Oncol Lett       Date:  2017-10-31       Impact factor: 2.967

2.  Expression and clinical significance of miR-338 and miR-20a in serum of patients with gastric carcinoma.

Authors:  Min Li; Jueping Feng; Chang Gao; Wen Sun; Yilian Chen
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

3.  miR-20a regulates sensitivity of colorectal cancer cells to NK cells by targeting MICA.

Authors:  Siwen Tang; Hongyu Fu; Qihua Xu; Ying Zhou
Journal:  Biosci Rep       Date:  2019-07-02       Impact factor: 3.840

4.  Circulating extracellular vesicle-encapsulated microRNA as screening biomarkers for intraductal papillary mucinous neoplasm.

Authors:  Yuki Sato; Rei Suzuki; Tadayuki Takagi; Mitsuru Sugimoto; Hiromasa Ohira
Journal:  Oncol Lett       Date:  2020-10-01       Impact factor: 2.967

5.  miR-765 Acts as a Tumor Promoter and Indicates Poor Prognosis in Non-Small Cell Lung Cancer.

Authors:  Jiying Wang; Li Wang; Congjun Zhang
Journal:  Onco Targets Ther       Date:  2021-08-04       Impact factor: 4.147

6.  Clinical value of miR-135 and miR-20a combined with multi-detector computed tomography in the diagnosis of gastric cancer.

Authors:  Wenwen Han; Xiangzhen Bu; Yanli Liu; Fang Liu; Yujie Ren; Yongsheng Cui; Shuhong Kong
Journal:  World J Surg Oncol       Date:  2021-09-18       Impact factor: 2.754

7.  Release of MicroRNAs into Body Fluids from Ten Organs of Mice Exposed to Cigarette Smoke.

Authors:  Alberto Izzotti; Mariagrazia Longobardi; Sebastiano La Maestra; Rosanna T Micale; Alessandra Pulliero; Anna Camoirano; Marta Geretto; Francesco D'Agostini; Roumen Balansky; Mark Steven Miller; Vernon E Steele; Silvio De Flora
Journal:  Theranostics       Date:  2018-03-08       Impact factor: 11.556

8.  Hsa_circ_0001649 restrains gastric carcinoma growth and metastasis by downregulation of miR-20a.

Authors:  Haiyuan Sun; Qunying Wang; Gang Yuan; Jingzi Quan; Dongfang Dong; Yue Lun; Bo Sun
Journal:  J Clin Lab Anal       Date:  2020-03-25       Impact factor: 2.352

9.  miR-22 promotes stem cell traits via activating Wnt/β-catenin signaling in cutaneous squamous cell carcinoma.

Authors:  Shukai Yuan; Peitao Zhang; Liqi Wen; Shikai Jia; Yufan Wu; Zhenlei Zhang; Lizhao Guan; Zhengquan Yu; Li Zhao
Journal:  Oncogene       Date:  2021-08-03       Impact factor: 9.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.